Drug – bio-affecting and body treating compositions – Antigen – epitope – or other immunospecific immunoeffector – Amino acid sequence disclosed in whole or in part; or...
Reexamination Certificate
2005-07-19
2005-07-19
Smith, L. F. (Department: 1645)
Drug, bio-affecting and body treating compositions
Antigen, epitope, or other immunospecific immunoeffector
Amino acid sequence disclosed in whole or in part; or...
C424S130100, C424S137100, C424S150100, C424S164100, C424S178100, C424S184100, C424S185100, C424S186100, C424S190100, C424S193100, C424S197110, C424S256100, C424S278100, C930S010000
Reexamination Certificate
active
06919080
ABSTRACT:
A novel peptide obtained fromHaemophilus paragallinarumhas been found useful for preventing avian infectious coryza. This polypeptide induces production of hemagglutination-inhibition antibody and prevents infection and onset of avian infectious coryza. The invention further provides a gene coding for the polypeptide, a recombinant vector for expression of this gene, a host transformed with this vector, a process for preparing the polypeptide in a host, a vaccine for avian infectious coryza comprising the polypeptide as an active ingredient, a monoclonal antibody obtained using the polypeptide as an immunogen, and a diagnostic agent and a therapeutic agent for avian infectious coryza using the peptide and the antibody.
REFERENCES:
patent: 4247539 (1981-01-01), Iritani et al.
patent: 4746613 (1988-05-01), Wichmann
patent: 5196514 (1993-03-01), Avakian et al.
patent: 5240705 (1993-08-01), Jacobs
patent: 5650153 (1997-07-01), Ishikawa et al.
patent: 6528310 (2003-03-01), Fujinaga et al.
patent: 5645416 (1981-04-01), None
patent: 56115724 (1981-09-01), None
patent: 64467 (1989-01-01), None
patent: 5112466 (1993-05-01), None
patent: 827028 (1996-01-01), None
Sawata et al., 1980. Biologic and Immunologic Studies on Three Types of Hemagglutinin ofH. paragallinarumSerotype 1. Am. J. Vet. Res. 41:1901-1904.
Yamaguchi et al. 1988. Avain Disease. 32: 308-312.
Kume et al. 1980. Immunologic Relationship between Page's and Sawata's Serotype Strains ofHaemophilus paragallinarum. Am. J. Vet. Res. 41:757-760.
Sawata et al. 1980. Biologic and Immunologic Studies on Three Types of Hemagglutinin ofHaemophilus paragallinarumSerotype 1 Organisms. Am/ J. Vet. Res. 41:1901-1904.
Yamaguchi et al. 1988. Serological Response of Chickens Either vaccinated or Artificially Infected withHaemophilus paragallinarum. Avain Disease. 32:308-312.
Iritani et al. 1988. Purification and Properties ofHaemophilus paragallinarumHemagglutinin. Am J. Vet. Res. 41:2114-2118.
Takagi et al. 1993. Purification of Hemagglutinin fromHaemophilus paragallinarumusing monoclonal antibody. Vet. Microbio. 34: 191-197.
Matsumoto, et al., “A Broth Bacterin Against Infectious Coryza: Immunogenicity of Various Preparations,”Avian Diseases, 18:109-117 (1971).
Otsuki, et al., “Preparation and Immunological Response to a New Mixed Vaccine Composed of Inactivated Newcastle Disease Virus, Inactivated Infectious Bronchitis Virus, and InactivatedHemophilus gallinarum,” Avian Diseases, 18(3):297-304 (1974).
Kume, et al., “Clearance of the Challenge Organisms from the Upper Respitory Tract of Chickens Injected with an InactivatedHaemophilus paragallinarumVaccine,”Jpn. J. Vet. Schi., 46:843-850 (1984).
Page, “Haemophilus Infectious in Chickens: I. Characteristics of 12 Haemophilus Isolates Recovered from Diseased Chickens,”Am. J. Vet. Res., 23:85-95 (1962).
Sawata, et al., “Jaemophilus Infectious in Chickens 2. types ofHaemophilus paragallinarumIslates from Chickens with Infectious Coryza, in Relation toHaemohilus gallinarumStrain No. 221,”Jpn. J. Vet. Sci., 40:645-652 (1978).
Kume, et al., “Immunologic Relationship Between Page's and Sawata's Serotype Strains ofHaemophilus paragallinarum,” Am. J. Vet. Res. 41:757-760 (1980).
Sawata, et al., “Biologic and Serologic Relationships Between Page's and Sawata's Serotypes ofHaemophilus paragallinarum,” Am. J. Vet. Res., 41:1901-1904 (1980).
Kume, et al., “Serologic and Immunologic Studies on Three Types of Hemagglutinin ofHaemophilus paragallinarumSerotype 1 Organisms,”Jpn. J. Vet. Sci., 45:783-792 (1983).
Sawata, et al., “Hemagglutinins ofHaemophilus paragallinarumSerotype 1 Organisms,”Jpn. J. Vet. Sci., 46:21-29 (1984).
Yamaguchi, et al., “Occurence of Two Haemagglutinins ofHaemophilus paragallinarumStrain 221 and Comparison of Their Properties,”Jpn. J. Vet. Sci., 42:709-711 (1980).
Iritani, et al., “Purification ofHaemophilus paragallinarumHemagglutinin,”Am. J. Vet. Res., 41:2114-2118 (1980).
Sawata, et al., “Hemagglutinin ofHaemophilus paragallinarumserotype 2 organisms: Occurence and immunologic properties of hemafflutinin,”Am. J. Vet. Res., 43:1311-1314 (1982).
Takagi, et al., “Purification of hemafflutinin fromHaemophilus paragallinarumusing monoclonal antibody,”Vet. Microbiol., 34:191-197 (1993).
Sawata, et al., “Bilogic and Immunologic Studies on Three Types of Hemafflutinin ofHaemophilus paragallinarumSerotype 1 Organisms,”Am. J. Vet. Res., 41:1901-1904 (1980).
Yamaguchi, et al., “Serological Response of Chickens either vaccinated or Artificially Infected withHaemophilus paragallinarum,” Avian Diseae, 32:308-312 (1988).
Database SRS Online: Fleischmann, et al. Haemophilus Influenzae Genome. Database accession No. U32845. Aug. 9, 1995.
Ben-Yehuda, et al. Recombinant Vaccinia Virus with Inifluenza Hemagglutinin Protects Old Mice from Influenze Infection. Transactions of the Association of American Physics. 105:177-181 (1992).
Ohuchi, et al. Mutations at the Cleavage Site of the Hemagglutinin Alter the Pathogenicity of Influenza Virus A/Chick/Penn/83 (H5N2). Virology. 168:274-280 (1989).
Jacobs, et al. Efficacy of a trivalentHaemophilus paragallinarumvaccine compared to bivalent vaccines. Veterinary Microbiology. 32:43-49 (1992).
Hamada Fukusaburo
Matsuo Kazuo
Sakaguchi Masashi
Tokiyoshi Sachio
Tokunaga Eiji
Browdy and Neimark , P.L.L.C.
Hines J.
Juridical Foundation The Chemo-Sero Therapeutic Research Institu
Smith L. F.
LandOfFree
Polypeptide for Haemophilus paragallinarum and process for... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Polypeptide for Haemophilus paragallinarum and process for..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Polypeptide for Haemophilus paragallinarum and process for... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3381157